nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimantadine—Pallor—Teniposide—lymphatic system cancer	0.0272	0.0272	CcSEcCtD
Rimantadine—Depression—Mechlorethamine—lymphatic system cancer	0.017	0.017	CcSEcCtD
Rimantadine—Cardiac failure—Fludarabine—lymphatic system cancer	0.0147	0.0147	CcSEcCtD
Rimantadine—Tinnitus—Mechlorethamine—lymphatic system cancer	0.0143	0.0143	CcSEcCtD
Rimantadine—Bronchospasm—Teniposide—lymphatic system cancer	0.0139	0.0139	CcSEcCtD
Rimantadine—Gait disturbance—Carmustine—lymphatic system cancer	0.013	0.013	CcSEcCtD
Rimantadine—Dysphagia—Fludarabine—lymphatic system cancer	0.0124	0.0124	CcSEcCtD
Rimantadine—Gait disturbance—Vincristine—lymphatic system cancer	0.0124	0.0124	CcSEcCtD
Rimantadine—Stomatitis—Teniposide—lymphatic system cancer	0.0123	0.0123	CcSEcCtD
Rimantadine—Sweating increased—Fludarabine—lymphatic system cancer	0.0121	0.0121	CcSEcCtD
Rimantadine—Mental disability—Carmustine—lymphatic system cancer	0.011	0.011	CcSEcCtD
Rimantadine—Stomatitis—Fludarabine—lymphatic system cancer	0.0108	0.0108	CcSEcCtD
Rimantadine—Anorexia—Mechlorethamine—lymphatic system cancer	0.0104	0.0104	CcSEcCtD
Rimantadine—Eye pain—Carmustine—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Rimantadine—Chills—Teniposide—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Rimantadine—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.00989	0.00989	CcSEcCtD
Rimantadine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00947	0.00947	CcSEcCtD
Rimantadine—Agitation—Teniposide—lymphatic system cancer	0.00904	0.00904	CcSEcCtD
Rimantadine—Bronchospasm—Bleomycin—lymphatic system cancer	0.00895	0.00895	CcSEcCtD
Rimantadine—Chills—Fludarabine—lymphatic system cancer	0.00892	0.00892	CcSEcCtD
Rimantadine—Cardiac failure—Mitoxantrone—lymphatic system cancer	0.00876	0.00876	CcSEcCtD
Rimantadine—Ataxia—Carmustine—lymphatic system cancer	0.00864	0.00864	CcSEcCtD
Rimantadine—Hypertension—Teniposide—lymphatic system cancer	0.0085	0.0085	CcSEcCtD
Rimantadine—Ataxia—Vincristine—lymphatic system cancer	0.00825	0.00825	CcSEcCtD
Rimantadine—Confusional state—Teniposide—lymphatic system cancer	0.0081	0.0081	CcSEcCtD
Rimantadine—Agitation—Fludarabine—lymphatic system cancer	0.00795	0.00795	CcSEcCtD
Rimantadine—Dysphagia—Carmustine—lymphatic system cancer	0.00794	0.00794	CcSEcCtD
Rimantadine—Stomatitis—Bleomycin—lymphatic system cancer	0.00791	0.00791	CcSEcCtD
Rimantadine—Tachycardia—Teniposide—lymphatic system cancer	0.00784	0.00784	CcSEcCtD
Rimantadine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00776	0.00776	CcSEcCtD
Rimantadine—Anorexia—Teniposide—lymphatic system cancer	0.00766	0.00766	CcSEcCtD
Rimantadine—Cough—Fludarabine—lymphatic system cancer	0.00755	0.00755	CcSEcCtD
Rimantadine—Convulsion—Fludarabine—lymphatic system cancer	0.00749	0.00749	CcSEcCtD
Rimantadine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00745	0.00745	CcSEcCtD
Rimantadine—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00725	0.00725	CcSEcCtD
Rimantadine—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00719	0.00719	CcSEcCtD
Rimantadine—Dyspnoea—Teniposide—lymphatic system cancer	0.00716	0.00716	CcSEcCtD
Rimantadine—Confusional state—Fludarabine—lymphatic system cancer	0.00712	0.00712	CcSEcCtD
Rimantadine—Depression—Carmustine—lymphatic system cancer	0.00706	0.00706	CcSEcCtD
Rimantadine—Decreased appetite—Teniposide—lymphatic system cancer	0.00698	0.00698	CcSEcCtD
Rimantadine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00693	0.00693	CcSEcCtD
Rimantadine—Stomatitis—Carmustine—lymphatic system cancer	0.0069	0.0069	CcSEcCtD
Rimantadine—Rash—Mechlorethamine—lymphatic system cancer	0.00687	0.00687	CcSEcCtD
Rimantadine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00686	0.00686	CcSEcCtD
Rimantadine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00682	0.00682	CcSEcCtD
Rimantadine—Depression—Vincristine—lymphatic system cancer	0.00674	0.00674	CcSEcCtD
Rimantadine—Anorexia—Fludarabine—lymphatic system cancer	0.00673	0.00673	CcSEcCtD
Rimantadine—Feeling abnormal—Teniposide—lymphatic system cancer	0.00662	0.00662	CcSEcCtD
Rimantadine—Stomatitis—Vincristine—lymphatic system cancer	0.00659	0.00659	CcSEcCtD
Rimantadine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00657	0.00657	CcSEcCtD
Rimantadine—Chills—Bleomycin—lymphatic system cancer	0.00654	0.00654	CcSEcCtD
Rimantadine—Nausea—Mechlorethamine—lymphatic system cancer	0.00647	0.00647	CcSEcCtD
Rimantadine—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00642	0.00642	CcSEcCtD
Rimantadine—Abdominal pain—Teniposide—lymphatic system cancer	0.00635	0.00635	CcSEcCtD
Rimantadine—Hallucination—Carmustine—lymphatic system cancer	0.00633	0.00633	CcSEcCtD
Rimantadine—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00633	0.00633	CcSEcCtD
Rimantadine—Dyspnoea—Fludarabine—lymphatic system cancer	0.00629	0.00629	CcSEcCtD
Rimantadine—Oedema peripheral—Carmustine—lymphatic system cancer	0.00626	0.00626	CcSEcCtD
Rimantadine—Dyspepsia—Fludarabine—lymphatic system cancer	0.00621	0.00621	CcSEcCtD
Rimantadine—Decreased appetite—Fludarabine—lymphatic system cancer	0.00614	0.00614	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00609	0.00609	CcSEcCtD
Rimantadine—Fatigue—Fludarabine—lymphatic system cancer	0.00609	0.00609	CcSEcCtD
Rimantadine—Hallucination—Vincristine—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Rimantadine—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Rimantadine—Constipation—Fludarabine—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Rimantadine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00582	0.00582	CcSEcCtD
Rimantadine—Asthenia—Teniposide—lymphatic system cancer	0.00576	0.00576	CcSEcCtD
Rimantadine—Cough—Bleomycin—lymphatic system cancer	0.00553	0.00553	CcSEcCtD
Rimantadine—Diarrhoea—Teniposide—lymphatic system cancer	0.0055	0.0055	CcSEcCtD
Rimantadine—Chills—Mitoxantrone—lymphatic system cancer	0.0053	0.0053	CcSEcCtD
Rimantadine—Confusional state—Bleomycin—lymphatic system cancer	0.00522	0.00522	CcSEcCtD
Rimantadine—Tremor—Carmustine—lymphatic system cancer	0.00519	0.00519	CcSEcCtD
Rimantadine—Vomiting—Teniposide—lymphatic system cancer	0.00511	0.00511	CcSEcCtD
Rimantadine—Agitation—Carmustine—lymphatic system cancer	0.00509	0.00509	CcSEcCtD
Rimantadine—Asthenia—Fludarabine—lymphatic system cancer	0.00506	0.00506	CcSEcCtD
Rimantadine—Rash—Teniposide—lymphatic system cancer	0.00506	0.00506	CcSEcCtD
Rimantadine—Dermatitis—Teniposide—lymphatic system cancer	0.00506	0.00506	CcSEcCtD
Rimantadine—Headache—Teniposide—lymphatic system cancer	0.00503	0.00503	CcSEcCtD
Rimantadine—Anorexia—Bleomycin—lymphatic system cancer	0.00493	0.00493	CcSEcCtD
Rimantadine—Agitation—Vincristine—lymphatic system cancer	0.00486	0.00486	CcSEcCtD
Rimantadine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00483	0.00483	CcSEcCtD
Rimantadine—Convulsion—Carmustine—lymphatic system cancer	0.0048	0.0048	CcSEcCtD
Rimantadine—Hypertension—Carmustine—lymphatic system cancer	0.00478	0.00478	CcSEcCtD
Rimantadine—Nausea—Teniposide—lymphatic system cancer	0.00477	0.00477	CcSEcCtD
Rimantadine—Anxiety—Carmustine—lymphatic system cancer	0.0047	0.0047	CcSEcCtD
Rimantadine—Dyspnoea—Bleomycin—lymphatic system cancer	0.00461	0.00461	CcSEcCtD
Rimantadine—Convulsion—Vincristine—lymphatic system cancer	0.00458	0.00458	CcSEcCtD
Rimantadine—Hypertension—Vincristine—lymphatic system cancer	0.00456	0.00456	CcSEcCtD
Rimantadine—Confusional state—Carmustine—lymphatic system cancer	0.00456	0.00456	CcSEcCtD
Rimantadine—Decreased appetite—Bleomycin—lymphatic system cancer	0.0045	0.0045	CcSEcCtD
Rimantadine—Cough—Mitoxantrone—lymphatic system cancer	0.00449	0.00449	CcSEcCtD
Rimantadine—Vomiting—Fludarabine—lymphatic system cancer	0.00449	0.00449	CcSEcCtD
Rimantadine—Convulsion—Mitoxantrone—lymphatic system cancer	0.00446	0.00446	CcSEcCtD
Rimantadine—Rash—Fludarabine—lymphatic system cancer	0.00445	0.00445	CcSEcCtD
Rimantadine—Dermatitis—Fludarabine—lymphatic system cancer	0.00445	0.00445	CcSEcCtD
Rimantadine—Hypertension—Mitoxantrone—lymphatic system cancer	0.00444	0.00444	CcSEcCtD
Rimantadine—Headache—Fludarabine—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Rimantadine—Tachycardia—Carmustine—lymphatic system cancer	0.00441	0.00441	CcSEcCtD
Rimantadine—Anxiety—Mitoxantrone—lymphatic system cancer	0.00437	0.00437	CcSEcCtD
Rimantadine—Anorexia—Carmustine—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Rimantadine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00427	0.00427	CcSEcCtD
Rimantadine—Confusional state—Mitoxantrone—lymphatic system cancer	0.00424	0.00424	CcSEcCtD
Rimantadine—Nausea—Fludarabine—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Rimantadine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00417	0.00417	CcSEcCtD
Rimantadine—Shock—Mitoxantrone—lymphatic system cancer	0.00413	0.00413	CcSEcCtD
Rimantadine—Anorexia—Vincristine—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Rimantadine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.0041	0.0041	CcSEcCtD
Rimantadine—Insomnia—Carmustine—lymphatic system cancer	0.00409	0.00409	CcSEcCtD
Rimantadine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00406	0.00406	CcSEcCtD
Rimantadine—Dyspnoea—Carmustine—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Rimantadine—Somnolence—Carmustine—lymphatic system cancer	0.00402	0.00402	CcSEcCtD
Rimantadine—Anorexia—Mitoxantrone—lymphatic system cancer	0.004	0.004	CcSEcCtD
Rimantadine—Ataxia—Methotrexate—lymphatic system cancer	0.004	0.004	CcSEcCtD
Rimantadine—Decreased appetite—Carmustine—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Rimantadine—Insomnia—Vincristine—lymphatic system cancer	0.0039	0.0039	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.0039	0.0039	CcSEcCtD
Rimantadine—Constipation—Carmustine—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Rimantadine—Decreased appetite—Vincristine—lymphatic system cancer	0.00375	0.00375	CcSEcCtD
Rimantadine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00374	0.00374	CcSEcCtD
Rimantadine—Somnolence—Mitoxantrone—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Rimantadine—Feeling abnormal—Carmustine—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Rimantadine—Fatigue—Vincristine—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Rimantadine—Asthenia—Bleomycin—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Rimantadine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Rimantadine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Rimantadine—Constipation—Vincristine—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Rimantadine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Rimantadine—Fatigue—Mitoxantrone—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Rimantadine—Constipation—Mitoxantrone—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Rimantadine—Abdominal pain—Carmustine—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Rimantadine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Rimantadine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Rimantadine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Rimantadine—Abdominal pain—Vincristine—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Rimantadine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00332	0.00332	CcSEcCtD
Rimantadine—Vomiting—Bleomycin—lymphatic system cancer	0.00329	0.00329	CcSEcCtD
Rimantadine—Depression—Methotrexate—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Rimantadine—Rash—Bleomycin—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Rimantadine—Dermatitis—Bleomycin—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Rimantadine—Asthenia—Carmustine—lymphatic system cancer	0.00324	0.00324	CcSEcCtD
Rimantadine—Stomatitis—Methotrexate—lymphatic system cancer	0.0032	0.0032	CcSEcCtD
Rimantadine—Asthenia—Vincristine—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Rimantadine—Diarrhoea—Carmustine—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Rimantadine—Nausea—Bleomycin—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Rimantadine—Asthenia—Mitoxantrone—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Rimantadine—Dizziness—Carmustine—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Rimantadine—Diarrhoea—Vincristine—lymphatic system cancer	0.00295	0.00295	CcSEcCtD
Rimantadine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Rimantadine—Vomiting—Carmustine—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Rimantadine—Dizziness—Vincristine—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Rimantadine—Rash—Carmustine—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Rimantadine—Dermatitis—Carmustine—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Rimantadine—Headache—Carmustine—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Rimantadine—Tinnitus—Methotrexate—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Rimantadine—Vomiting—Vincristine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Rimantadine—Rash—Vincristine—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Rimantadine—Dermatitis—Vincristine—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Rimantadine—Headache—Vincristine—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Rimantadine—Nausea—Carmustine—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Rimantadine—Vomiting—Mitoxantrone—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Rimantadine—Rash—Mitoxantrone—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Rimantadine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Rimantadine—Chills—Methotrexate—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Rimantadine—Headache—Mitoxantrone—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Rimantadine—Nausea—Vincristine—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Rimantadine—Nausea—Mitoxantrone—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Rimantadine—Cough—Methotrexate—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Rimantadine—Convulsion—Methotrexate—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Rimantadine—Confusional state—Methotrexate—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Rimantadine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Rimantadine—Anorexia—Methotrexate—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Rimantadine—Insomnia—Methotrexate—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Rimantadine—Dyspnoea—Methotrexate—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Rimantadine—Somnolence—Methotrexate—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Rimantadine—Dyspepsia—Methotrexate—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Rimantadine—Decreased appetite—Methotrexate—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Rimantadine—Fatigue—Methotrexate—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Rimantadine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Rimantadine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Rimantadine—Abdominal pain—Methotrexate—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Rimantadine—Asthenia—Methotrexate—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Rimantadine—Diarrhoea—Methotrexate—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Rimantadine—Dizziness—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Rimantadine—Vomiting—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Rimantadine—Rash—Methotrexate—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Rimantadine—Dermatitis—Methotrexate—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Rimantadine—Headache—Methotrexate—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Rimantadine—Nausea—Methotrexate—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
